Is PET-CT the only option?
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Accurate determination of the anatomic location of normal and pathological sites visualized on PET undoubtedly facilitates optimal interpretation of PET studies. It is now well established that image fusion with structural studies improves the diagnostic accuracy of images generated by PET . PET images can be fused with CT and/or MRI either by using co-registration algorithms for PET and CT scans which have been acquired separately or by using combined PET-CT instruments. However, combined PET-CT scanners have certain advantages. Sequential acquisition of PET and CT images (one immediately after the other) minimizes patient and organ motion artifacts since the patient is positioned almost identically for both scans . Furthermore, the CT data can be used for attenuation correction (AC) of the PET emission scan [3, 4]. Traditionally, an external radionuclide source has been employed for this purpose, but the use of CT for AC provides several advantages: First, the transmission scan
- Kluetz PG, Meltzer CC, Villemagne VL, Kinahan PE, Chander S, Martinelli MA, et al. Combined PET/CT imaging in oncology: impact on patient management. Clin Positron Imaging 2000;3:223–30. CrossRef
- Townsend DW, Carney JP, Yap JT, Hall NC. PET/CT today and tomorrow. J Nucl Med 2004;45 Suppl 1:4S–14S.
- Beyer T, Townsend D, Brun T, Kinahan PE, Charron M, Roddy R, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369–79.
- Nakamoto Y, Osman M, Cohade C, Marshall LT, Links JM, Kohlmyer S, et al. PET/CT: comparison of quantitative tracer uptake between germanium and CT transmission attenuation-corrected images. J Nucl Med 2002;43:1137–43.
- Lardinois D, Weder W, Hany T, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med 2003;348:2500–7. CrossRef
- Brahme A. Biologically optimized 3-dimensional in vivo predictive assay-based radiation therapy using positron emission tomography-computerized tomography imaging. Acta Oncol 2003;42:123–36. CrossRef
- Goerres GW, von Schulthess GK, Steinert HC. Why most PET of lung and head-and-neck cancer will be PET/CT. J Nucl Med 2004;45 Suppl 1:66S–71S.
- Wahl RL. Why nearly all PET of abdominal and pelvic cancers will be performed as PET/CT. J Nucl Med 2004;45 Suppl 1:82S–95S.
- Osman M, Cohade C, Nakamoto Y, Wahl R. Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT. Eur J Nucl Med Mol Imaging 2003;30:603–6. CrossRef
- Osman MM, Cohade C, Nakamoto Y, Marshall LT, Leal JP, Wahl RL. Clinically significant inaccurate localization of lesions with PET/CT: frequency in 300 patients. J Nucl Med 2003;44:240–3.
- Nakamoto Y, Chin BB, Cohade C, Osman M, Tatsumi M, Wahl RL. PET/CT: artifacts caused by bowel motion. Nucl Med Commun 2004;25:221–5. CrossRef
- Cohade C, Wahl RL. Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography—clinical use, interpretation methods, diagnostic improvements. Semin Nucl Med 2003;33:228–37. CrossRef
- Beyer T, Antoch G, Blodgett T, Freudenberg LF, Akhurst T, Mueller S. Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging 2003;30:588–96. CrossRef
- Goerres GW, Kamel E, Seifert B, Burger C, Buck A, Hany TF, et al. Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med 2002;43:1469–75.
- Kinahan PE, Hasegawa BH, Beyer T. X-ray-based attenuation correction for positron emission tomography/computed tomography scanners. Semin Nucl Med 2003;33:166–79. CrossRef
- Antoch G, Freudenberg LS, Egelhof T, Stattaus J, Jentzen W, Debatin JF, et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med 2002;43:1339–42.
- Cohade C, Osman M, Nakamoto Y, Marshall LT, Links JM, Fishman EK, et al. Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 2003;44:412–6.
- Bockisch A, Beyer T, Antoch G, Freudenberg LS, Kuhl H, Debatin JF, et al. Positron emission tomography/computed tomography—imaging protocols, artifacts, and pitfalls. Mol Imaging Biol 2004;6(4):188–99. CrossRef
- Antoch G, Freudenberg LS, Beyer T, Bockisch A, Debatin JF. To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT. J Nucl Med 2004;45 Suppl 1:56S–65S.
- Woods R, Mazziotta J, Cherry S. MRI-PET registration with automated algorithm. J Comput Assist Tomogr 1993;17:536–46. CrossRef
- West J, Fitzpatrick JM, Wang MY, Dawant BM, Maurer CR Jr, Kessler RM, et al. Comparison and evaluation of retrospective intermodality brain image registration techniques. J Comput Assist Tomogr 1997;21:554–66. CrossRef
- Krishnasetty V, Fischman AJ, Halpern EL, Aquino SL. Comparison of alignment of computer-registered data sets: combined PET/CT versus independent PET and CT of the thorax. Radiology 2005;237:635–9. CrossRef
- Schiepers C, Filmont J, Czernin J. PET for staging of Hodgkin’s disease and non-Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging 2003;30 Suppl 1:S82–8. CrossRef
- la Fougere C, Hundt W, Brockel N, Pfluger T, Haug A, Scher B, et al. Value of PET/CT versus PET and CT performed as separate investigations in patients with Hodgkin’s disease and non-Hodgkin’s lymphoma. Eur J Nucl Med Mol Imaging 2006;33:1417–25. CrossRef
- Alavi A, Gupta N, Alberini JL, Hickeson M, Adam LE, Bhargava P, et al. Positron emission tomography imaging in nonmalignant thoracic disorders. Semin Nucl Med 2002;32:293–321. CrossRef
- Kiffer JD, Berlangieri SU, Scott AM, Quong G, Feigen M, Schumer W, et al. The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer 1998;19:167–77. CrossRef
- Paulino AC, Thorstad WL, Fox T. Role of fusion in radiotherapy treatment planning. Semin Nucl Med 2003;33 3:238–43. CrossRef
- von Schulthess GK. Positron emission tomography versus positron emission tomography/computed tomography: from “unclear” to “new-clear” medicine. Mol Imaging Biol 2004;6 4:183–7. CrossRef
- Beyer T, Townsend DW. Putting ‘clear’ into nuclear medicine: a decade of PET/CT development. Eur J Nucl Med Mol Imaging 2006;33:857–61. CrossRef
- Is PET-CT the only option?
European Journal of Nuclear Medicine and Molecular Imaging
Volume 34, Issue 6 , pp 819-821
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Division of Nuclear Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 19104, USA
- 3. Division of Nuclear Medicine, Yeditepe University, Istanbul, Turkey
- 2. Department of Radiology, Massachusetts General Hospital, Boston, MA, 02114, USA